At 38.9x earnings and 26.3x forward earnings, the market is clearly pricing TDG as a premium compounder, not a cyclical industrial. The forward compression from 38.9 to 26.3 implies a meaningful earnings inflection, supported by EPS rising from 20.7 to an estimated 31.08, but the 2.1 PEG suggests investors are still paying up for that growth. Financially, this is not a fortress balance sheet story: an Altman Z-Score of 1.8 sits in the distress zone, and a negative operating margin of -19.50% is a glaring inconsistency against a 16.70% ROIC. This is a high-expectation stock priced for execution perfection, with solvency metrics that demand respect rather than complacency.